Publication | Closed Access

Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials

InflammationPrognostic BiomarkersBreast OncologyCancer ImmunosurveillanceMedicinePrognostic ValueImmunologyClinical TrialsImmune Checkpoint InhibitorBreast CancerProspective TrialsImmunotherapyOncologyRadiation OncologyExploratory AnalysisHealth Sciences